Brez internetne povezave — prikazana je shranjena različica strani.

Sanofi ADR

USUSD
← Na filter delnic

Sanofi ADR (PA:SAN) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 6. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O podjetju

Spletna stran
sanofi.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
PARIS, France
Izvršni direktor
Paul Hudson
Zaposleni
106 566
Ustanovljena
2004
Na borzi od
03.01.2000 (PA:SAN)
Delnice v obtoku
1.22 mrd. na dan 2025-12-31
Prosto prenosljive delnice
2.16 mrd.
Tržna kapitalizacija
98.67 mrd. USD
Notranje osebe
0%
Institucionalni vlagatelji
8.02%
Panoga (SIC)
Pharmaceutical Preparations
Pravna oblika
QVPB
ISIN
FR0000120578
LEI
549300E9PC51EN656011
Delež izplačila
≈64.0%
FCF
10.8 mrd. EUR
47%
Dolg
18.7 mrd. EUR
1.0 let FCF
Dividendni staž
23 let
Dobički, FCF in izplačane dividende — za 12 mesecev do 31.12.2025 (najnovejše poročilo podjetja).
Opis

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Borze in oznake

BorzaOznakaValutaCenaVrsta
US USA StocksSNYNF OTCUSD78.99 -1.19%navadne delnice
LSE London Stock Exchange0O59 IOBEUR71.63 +0.72%navadne delnice
MI Borsa Italiana (Milan)1SAN dodatnaEUR71.64 +0.90%navadne delnice
PA Euronext ParisSAN glavnaEUR71.52 +0.83%navadne delnice
VI Vienna Stock ExchangeSANO dodatnaEUR71.3 +1.03%navadne delnice
XETRA XetraSNW dodatnaEUR71.78 -1.21%navadne delnice

Cena v 3 mesecih

dan rasti dan padca ex-dividendni datum datum izplačilaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Dividende

Per year, PA:SAN: 4.12 EUR (1 izpl.)

Sanofi ADR (SAN) izplačuje dividende enkrat letno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 4.12 EUR na delnico (plačila: 1). To je približno 5.76% trenutne cene delnice. Glede na zgodovino izplačil se naslednji datum ex-dividende pričakuje okoli 04.05.2027. Leta neprekinjenih dividend: 23.

Ex-datumIzplačiloZnesek%VrstaOznaka
2026-05-052026-05-074.1200 EUR5.8/5.8 %letnoPA:SAN
2025-05-122025-05-143.9200 EUR5.5/5.5 %letnoPA:SAN
2024-05-13—3.7600 EUR5.3/10.2 %letnoPA:SAN
2023-05-30—3.5600 EUR5.0/5.0 %letnoPA:SAN
2022-05-06—3.3300 EUR4.7/4.7 %letnoPA:SAN
oglas

Največji imetniki

ImetnikDeležDelniceDatum poročila
Dodge & Cox Inc.10.54%28.09 mio.2026-06-30
Dodge & Cox Funds-Dodge…7.84%20.9 mio.2026-06-30
Morgan Stanley4.02%10.7 mio.2026-06-30
Fisher Asset Management,…3.99%10.63 mio.2026-06-30
Bank of America Corporat…3%8.01 mio.2026-06-30
Invesco Ltd.2.55%6.8 mio.2026-06-30
JPMORGAN CHASE & CO2.47%6.57 mio.2026-06-30
Mondrian Investment Part…2.07%5.52 mio.2026-06-30
Brandes Investment Partn…1.55%4.14 mio.2026-06-30
AIM Sector Funds (Invesc…1.51%4.03 mio.2026-04-30
Federated Hermes, Inc.1.44%3.85 mio.2026-06-30
Boston Partners1.44%3.84 mio.2026-06-30
VANGUARD STAR FUNDS-Vang…1.31%15.85 mio.2026-07-31
Putnam ETF Trust-Putnam…1.26%3.36 mio.2026-05-31
VANGUARD TAX-MANAGED FUN…0.87%10.53 mio.2026-06-30
iShares Trust-iShares Co…0.67%8.11 mio.2026-08-31
Dodge & Cox Funds-Dodge…0.63%1.67 mio.2026-06-30
AMERICAN MUTUAL FUND0.59%1.58 mio.2026-06-30
American Century Capital…0.37%976 5612026-06-30
Bridge Builder Trust-Bri…0.36%967 1002026-06-30
Fidelity Concord Street…0.35%4.24 mio.2026-07-31
VanEck ETF Trust-VanEck…0.35%938 5612026-08-31
Dodge & Cox Funds-Dodge…0.33%4.04 mio.2026-06-30
iShares Trust-iShares MS…0.32%3.89 mio.2026-08-31
Capital World Growth & I…0.3%3.67 mio.2026-06-30
-Victory Pioneer Core Eq…0.3%799 4872026-06-30
Fidelity Covington Trust…0.3%797 1842026-08-31
NEW PERSPECTIVE FUND0.29%3.56 mio.2026-06-30
Federated Hermes Eqy. Fd…0.29%3.48 mio.2026-07-31
Bridge Builder Trust-Bri…0.29%3.44 mio.2026-06-30
Pacer Advisors, Inc.0.1%1.16 mio.2026-06-30
Generali Investments Cee…0%29 3392026-06-30
Paradigm Asset Managemen…0%19 2002026-06-30
Gamma Investing LLC0%582026-06-30
L'Oréal———